Various Advanced Cancer clinical trials at UCSF
1 in progress, 1 open to new patients
An Investigational Immuno-therapy Study of Nivolumab, Compared to Placebo, in Patients With Bladder or Upper Urinary Tract Cancer, Following Surgery to Remove the Cancer
open to eligible people ages 18 years and up
The purpose of this study is to determine the effectiveness and safety of Nivolumab compared to placebo in participants who have undergone radical surgery for invasive urothelial cancer.
Fresno, California and other locations